Zhangzhou Pientzehuang Pharmaceutical | 600436 - Eigenkapital Und Reserven

Aktienkurs
148.56
Täglich Wechseln
-0.21 -0.14%
Monatlich
-7.80%
Jährlich
-27.81%
Q2 Prognose
147.70




Eigenkapital Und Reserven Veränderung Datum
Akebia Therapeutics USD 32.61M 8.98M 2025-12
Alaunos Therapeutics USD 2.8M 858K 2025-09
Avita Medical AUD -16.65M 3.76M 2025-12
Cspc Pharmaceutical CNY 33.18B 71.46M 2025-12
Dianthus Therapeutics USD 493.4M 53.05M 2025-12
Ionis Pharmaceuticals USD 617.97M 13.76M 2025-09
IQVIA Holdings USD 6.5B 343M 2025-12
Jiangsu Hengrui CNY 61.27B 1.77B 2025-12
Kangmei Pharma CNY 7.22B 504.3M 2025-09
Moderna USD 8.65B 680M 2025-12
Revvity USD 7.38B 180.27M 2025-09
Sh Fosun Pharma CNY 49.39B 11.42B 2025-12
Tectonic Therapeutic USD 251.33M 16.2M 2025-12
Viatris USD 15.22B 352.9M 2025-09
Wuxi Apptec CNY 80.66B 9.19B 2025-12
Xeris Pharmaceuticals USD 13.69M 14.55M 2025-12
Zz Pientze Pharmaceu CNY 14.47B 173.2M 2025-09